DZ Bank
BLRX

DZ Bank’s BioLineRX BLRX Stock Holding History

DZ Bank’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,310
Closed -$684K – 883
2018
Q1 		$684K Buy
+1,310
New +$803K ﹤0.01% 739

Other funds holding BLRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BCA
Benchmark Capital Advisors New York $101M AUM 0.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DZ Bank's BLRX Position: Q2 2018 in Review

DZ Bank sold out of BioLineRX (BLRX) in Q2 2018, closing a stake of 1,310 shares — an estimated $684K sold.

DZ Bank first reported a position in BLRX in Q1 2018 and held it in 1 quarter. The position peaked at $684K in Q1 2018. 25 funds tracked by Wall St. Rank hold BLRX as of Q2 2018.

  • DZ Bank reported no remaining BioLineRX position as of Q2 2018 after selling out during the quarter.
  • DZ Bank sold 1,310 BioLineRX shares in Q2 2018, an estimated $684K.
  • DZ Bank first reported a position in BioLineRX in Q1 2018 and held it in 1 quarter.
  • DZ Bank's BioLineRX position peaked at $684K in Q1 2018.
  • 25 funds tracked by Wall St. Rank held BioLineRX as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.